Launch of Consumer Health Intelligence Service Onegevity Combines Blood, Genome and Microbiome Analysis for Personalized Health and Wellness
Summary
Onegevity will provide a comprehensive molecular portrait and customized recommendations for an individual’s health based on integrated analysis of longitudinal blood, genetics, and gut microbiome profiles. Onegevity will leverage partner company Thorne’s network of 35,000 physicians to offer convenient testing and powerful analytical tools to improve preventative care and lower healthcare costs for their patients. “Ten years ago, genetic and microbiome sequencing were isolated to advanced research groups and the ultrawealthy at costs in excess of $50,000 and provided limited insights,” said Dr. Mason, who is a co-founder, equity stakeholder, and consultant for Onegevity. His >150 published papers have pioneered new biochemical and computational methods in next-generation sequencing, detection of DNA and RNA modifications, and metagenome profiling, working closely with the NIST/FDA to build global genomics standards and NASA for multi-omic models. These efforts span across a range of applications, such as sports concussion, cognition in aging, Parkinson’s disease, ketogenic nutrition, cancer supportive care, irritable bowel syndrome, athletic performance, and others.